# Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea

> **NCT01177410** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 148 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DRUG:** Placebo
- **DRUG:** Mesalamine Granules 750 mg
- **DRUG:** Mesalamine Granules 1500 mg

## Key facts

- **NCT ID:** NCT01177410
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01177410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01177410, "Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01177410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*